PolarCool’s Board and Management increase their subscription in the company's ongoing rights issue to a total of 455 TSEK

The med-tec company PolarCool AB (publ) announces that the companies’ Chairman of the Board Gustaf Frithz, and board members Håkan Samuelsson and Pär Carmonius have subscribed for shares in the ongoing rights issue by using subscription rights and have also chosen to subscribe for an increased number of shares that follows from the subscription commitments.

Altogether, this means that PolarCool's board and management have subscribed for shares with the support of subscription rights corresponding to a total of approximately 455 TSEK (compared to commitments of 235 TSEK). Chairman Gustaf Frithz subscribes for 100 TSEK, members Mats Forsman for 85 TSEK, Håkan Samuelsson for 120 TSEK, Pär Carmonius for 50 TSEK and CEO Erik Andersson for 100 TSEK.

The subscription period for PolarCool's rights issue ends on March 3, 2023.

PolarCool CEO Erik Andersson comments;

-The board and I strongly believe in the company and welcome everyone, also new shareholders without subscription rights, to participate in the issue. The registration form, prospectus and teaser are available on Nordic Issuing's website nordic-issuing.se and on Spotlight Stock Market's website www.spotlightstockmarket.com/and on www.polarcool.se.

 For more information

Erik Andersson –  CEO PolarCool AB (publ)               
+46 - 738 60 57 00                                         
E-mail: erik.andersson@polarcool.se 

About PolarCool AB (publ)

PolarCool AB (publ) is a medical device company that develops, markets, and sells products for sports medicine. The company focuses on treatment of concussive and sub-concussive brain injury with the portable cooling device PolarCap® System. PolarCool AB (publ) is based in Lund, Sweden, and its shares are listed on Spotlight Stock Market.